Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Stanford Medicine
Stanford, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
Mayo Clinic
Rochester, United States
Heidelberg University
Heidelberg, Germany
University of Southampton
Southampton, United Kingdom
University of Chicago
Chicago, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Texas Tech University Health Sciences Center
Lubbock, United States
Massachusetts General Hospital
Boston, United States
University of Milan
Milan, Italy
References
References (69)
- 1
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.
Gotlib J
Current hematologic malignancy reports 2015; (10(4)):351-61 doi:10.1007/s11899-015-0280-3.
PMID: 26404639 - 2
Hypereosinophilic syndrome: cardiac diagnosis and management.
Mankad R, Bonnichsen C, Mankad S
Heart (British Cardiac Society) 2016; (102(2)):100-6 doi:10.1136/heartjnl-2015-307959.
PMID: 26567231 - 3
BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia.
He R, Greipp PT, Rangan A, et al.
Cancer genetics 2016; (209(5)):223-8.
PMID: 27134074 - 4
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Pemmaraju N, Gupta V, Thompson MA, Lane AA
Current hematologic malignancy reports 2016; (11(6)):462-467 doi:10.1007/s11899-016-0340-3.
PMID: 27492117 - 5
Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".
Bauml JM, Troxel A, Epperson CN, et al.
Lung cancer (Amsterdam, Netherlands) 2016; (100()):110-113 doi:10.1016/j.lungcan.2016.08.002.
PMID: 27597289 - 6
Myeloid neoplasms with eosinophilia.
Reiter A, Gotlib J
Blood 2017; (129(6)):704-714 doi:10.1182/blood-2016-10-695973.
PMID: 28028030 - 7
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.
Tang G, Sydney Sir Philip JK, Weinberg O, et al.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019; (32(4)):490-498 doi:10.1038/s41379-018-0165-9.
PMID: 30401948 - 8
Idiopathic Hypereosinophilic Syndrome in an Elderly Female: A Case Report.
Khalid F, Holguin F
The American journal of case reports 2019; (20()):381-384 doi:10.12659/AJCR.912747.
PMID: 30902963 - 9
A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease.
Diamond EL, Reiner AS, Buthorn JJ, et al.
Blood advances 2019; (3(7)):934-938 doi:10.1182/bloodadvances.2018030502.
PMID: 30917949 - 10
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
American journal of hematology 2019; (94(10)):1149-1167 doi:10.1002/ajh.25617.
PMID: 31423623 - 11
[Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].
Liu YT, Zhao JW, Feng J, et al.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2019; (40(10)):848-852 doi:10.3760/cma.j.issn.0253-2727.2019.10.010.
PMID: 31775485 - 12
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Al-Ali HK, Griesshammer M, Foltz L, et al.
British journal of haematology 2020; (189(5)):888-903 doi:10.1111/bjh.16462.
PMID: 32017044 - 13
The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and ZBTB20-JAK2 gene fusion presenting as B-lymphoblastic leukemia.
Lee WY, Pfau RB, Choi SM, et al.
Cold Spring Harbor molecular case studies 2020; (6(2)) doi:10.1101/mcs.a004937.
PMID: 32238402 - 14
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Schwaab J, Naumann N, Luebke J, et al.
American journal of hematology 2020; (95(7)):824-833 doi:10.1002/ajh.25825.
PMID: 32279331 - 15
Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
Snider JS, Znoyko I, Lindsey KG, et al.
Cancer genetics 2020; (246-247()):44-47 doi:10.1016/j.cancergen.2020.08.004.
PMID: 32827877 - 16
Loeffler's Endocarditis: An Integrated Multimodality Approach.
Polito MV, Hagendorff A, Citro R, et al.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2020; (33(12)):1427-1441 doi:10.1016/j.echo.2020.09.002.
PMID: 33129649 - 17
Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia.
Zhang XY, Dai HP, Li Z, et al.
Frontiers in oncology 2020; (10()):611467 doi:10.3389/fonc.2020.611467.
PMID: 33505919 - 18
Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era.
Pemmaraju N, Wilson NR, Clementi Doan T, et al.
Leukemia & lymphoma 2021; (62(9)):2253-2260 doi:10.1080/10428194.2021.1901096.
PMID: 33749512 - 19
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature.
Santoro M, Rotolo C, Accurso V, et al.
Chemotherapy 2021; (66(3)):87-91 doi:10.1159/000515430.
PMID: 33784668 - 20
Scanxiety: a scoping review about scan-associated anxiety.
Bui KT, Liang R, Kiely BE, et al.
BMJ open 2021; (11(5)):e043215 doi:10.1136/bmjopen-2020-043215.
PMID: 34039571 - 21
Hypereosinophilic syndrome: considerations for the cardiologist.
Bondue A, Carpentier C, Roufosse F
Heart (British Cardiac Society) 2022; (108(3)):164-171 doi:10.1136/heartjnl-2020-317202.
PMID: 34172539 - 22
Normalization of left ventricular filling pressure after cardiac surgery for the Loeffler's endocarditis: a case report.
Carcaterra A, Mock S, Müller H, Testuz A
European heart journal. Case reports 2021; (5(6)):ytab189 doi:10.1093/ehjcr/ytab189.
PMID: 34263118 - 23
Synoptic Diagnostics of Myeloproliferative Neoplasms: Morphology and Molecular Genetics.
Nann D, Fend F
Cancers 2021; (13(14)) doi:10.3390/cancers13143528.
PMID: 34298741 - 24
Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm.
Lap CJ, Nassereddine S, Liu ML, et al.
Case reports in hematology 2021; (2021()):2348977 doi:10.1155/2021/2348977.
PMID: 34367701 - 25
Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance.
Chen JA, Hou Y, Roskin KM, et al.
Blood advances 2021; (5(17)):3492-3496 doi:10.1182/bloodadvances.2020004174.
PMID: 34505882 - 26
World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
American journal of hematology 2022; (97(1)):129-148 doi:10.1002/ajh.26352.
PMID: 34533850 - 27
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis.
Devos T, Selleslag D, Granacher N, et al.
Hematology (Amsterdam, Netherlands) 2022; (27(1)):23-31 doi:10.1080/16078454.2021.2009645.
PMID: 34957926 - 28
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia.
Rizzuto G, Leoncin M, Imbergamo S, et al.
Clinical case reports 2022; (10(1)):e05212 doi:10.1002/ccr3.5212.
PMID: 35028141 - 29
Contribution of imaging modalities to eosinophilic myocarditis diagnosis: a case report.
Farhat N, Bouhabib M, Joye R, et al.
European heart journal. Case reports 2022; (6(2)):ytac058 doi:10.1093/ehjcr/ytac058.
PMID: 35295721 - 30
Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies.
Zhao Y, Chen P, Dou L, et al.
Drug design, development and therapy 2022; (16()):817-825 doi:10.2147/DDDT.S354270.
PMID: 35370398 - 31
PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.
Kaplan HG, Jin R, Bifulco CB, et al.
The oncologist 2022; (27(8)):e661-e670 doi:10.1093/oncolo/oyac072.
PMID: 35472244 - 32
PCM1::JAK2 fusion associates with an atypical form of mycosis fungoides.
Rodriguez-Sevilla JJ, Salido M, Rodriguez-Rivera M, et al.
Virchows Archiv : an international journal of pathology 2022; (481(6)):967-973 doi:10.1007/s00428-022-03372-x.
PMID: 35786767 - 33
Updates on eosinophilic disorders.
Tzankov A, Reichard KK, Hasserjian RP, et al.
Virchows Archiv : an international journal of pathology 2023; (482(1)):85-97 doi:10.1007/s00428-022-03402-8.
PMID: 36068374 - 34
Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Voeller J, DeNapoli T, Griffin TC
Cancer reports (Hoboken, N.J.) 2022; (5(11)):e1710 doi:10.1002/cnr2.1710.
PMID: 36241191 - 35
Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review.
Houthuys JF, Wilmer AP, Peetermans M, et al.
Heliyon 2022; (8(12)):e11782 doi:10.1016/j.heliyon.2022.e11782.
PMID: 36478803 - 36
Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease.
Lebon D, Dujardin A, Caulier A, et al.
Leukemia research 2023; (125()):107005 doi:10.1016/j.leukres.2022.107005.
PMID: 36580876 - 37
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Zhang Y, Nguyen L, Lu CM, et al.
Clinical lymphoma, myeloma & leukemia 2023; (23(3)):e150-e163 doi:10.1016/j.clml.2022.12.008.
PMID: 36624015 - 38
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial.
El-Jawahri A, Luskin MR, Greer JA, et al.
Cancer 2023; (129(7)):1075-1084 doi:10.1002/cncr.34645.
PMID: 36655338 - 39
Evaluation of myocardial performance by serial speckle tracking echocardiography in diagnosis and follow-up of a patient with eosinophilic myocarditis.
Sharifkazemi M, Rezaian G, Lotfi M
Echo research and practice 2023; (10(1)):1 doi:10.1186/s44156-022-00013-6.
PMID: 36698163 - 40
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L, Shah B, Zhang Y, et al.
Human pathology 2023; (136()):1-15 doi:10.1016/j.humpath.2023.03.002.
PMID: 36958463 - 41
Defining ruxolitinib failure and transition to next-line therapy for patients with myelofibrosis: a modified Delphi panel consensus study.
Mascarenhas J, Nguyen H, Saunders A, et al.
Future oncology (London, England) 2023; (19(11)):763-773 doi:10.2217/fon-2022-1298.
PMID: 37161798 - 42
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management.
Collini V, Burelli M, Favaretto V, et al.
Minerva cardiology and angiology 2023; (71(5)):535-552 doi:10.23736/S2724-5683.23.06287-7.
PMID: 37161920 - 43
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA, Orazi A, Gotlib J, et al.
American journal of hematology 2023; (98(8)):1286-1306 doi:10.1002/ajh.26966.
PMID: 37283522 - 44
Rapid Hepatomegaly From Ruxolitinib Discontinuation Syndrome.
van Rensburg RJ, Hale S, Calara A, et al.
HCA healthcare journal of medicine 2023; (4(2)):199-204 doi:10.36518/2689-0216.1518.
PMID: 37424984 - 45
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G, Steiner L, Naumann N, et al.
Leukemia 2023; (37(9)):1860-1867 doi:10.1038/s41375-023-01958-1.
PMID: 37454239 - 46
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
Saft L, Kvasnicka HM, Boudova L, et al.
Histopathology 2023; (83(6)):829-849 doi:10.1111/his.15021.
PMID: 37551450 - 47
Sustained Response to Ruxolitinib of Eosinophilia-Associated Myeloproliferative Neoplasm with Translocation t(8;9)(p21;p24).
Cai P, Liu S, Duan L, et al.
Acta haematologica 2023; (146(5)):397-400 doi:10.1159/000510281.
PMID: 37562364 - 48
T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J, Gervasoni J, Guillermin Y, et al.
Virchows Archiv : an international journal of pathology 2024; (484(5)):853-857 doi:10.1007/s00428-023-03693-5.
PMID: 37985498 - 49
Hypereosinophilic syndrome associated with multiple thromboses requiring ICU admission: A case report.
Ouanes I, Toumi S, Ben Cheikh Y, et al.
La Tunisie medicale 2023; (101(10)):783-786.
PMID: 38465762 - 50
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
American journal of hematology 2024; (99(5)):946-968 doi:10.1002/ajh.27287.
PMID: 38551368 - 51
How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.
Reiter A, Metzgeroth G, Cross NCP
Blood 2025; (145(16)):1758-1768 doi:10.1182/blood.2023022417.
PMID: 39046810 - 52
TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition.
Lazarevic V, Lilljebjörn H, Olsson-Arvidsson L, et al.
Genes, chromosomes & cancer 2024; (63(8)):e23261 doi:10.1002/gcc.23261.
PMID: 39105620 - 53
A chain mediation model reveals the association between metacognition and quality of life in hematologic tumor patients.
Cheng C, Zheng M, Yan F, et al.
Scientific reports 2024; (14(1)):18446 doi:10.1038/s41598-024-69027-w.
PMID: 39117715 - 54
Efficacy and safety of ruxolitinib vs best available therapy for polycythemia vera: An updated systematic review and meta-analysis.
Roca Mora MM, Afzal F, Guimaraes CR, et al.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2024; (132(11)):775-786 doi:10.1111/apm.13472.
PMID: 39377511 - 55
Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies.
Ngo TQ, Goh AFN, Dorwal P, et al.
Pathology 2025; (57(3)):340-347 doi:10.1016/j.pathol.2024.09.009.
PMID: 39672769 - 56
A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement.
Zhou W, Guo X, Liu Y, et al.
Case reports in oncology 2025; (18(1)):190-197 doi:10.1159/000542692.
PMID: 39980500 - 57
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
Polverelli N, Hernández-Boluda JC, Onida F, et al.
Blood 2025; (145(22)):2561-2573 doi:10.1182/blood.2024028000.
PMID: 40106773 - 58
Identification and Confirmation of Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement and Characterization of Treatment Patterns and Outcomes in a Real-World Setting: A US Retrospective Chart Review.
Parasuraman S, Saverno K, Zimmerman Savill KM, Colucci P
Acta haematologica 2026; (149(3)):252-262 doi:10.1159/000546910.
PMID: 40618748 - 59
Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis.
Blanco-Sánchez A, Ayala R, Carreño-Tarragona G, et al.
EJHaem 2025; (6(6)):e70152 doi:10.1002/jha2.70152.
PMID: 41169484 - 60
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes.
Salmon M, Naumann N, Rinke J, et al.
Leukemia 2026; (40(1)):37-46 doi:10.1038/s41375-025-02801-5.
PMID: 41254115 - 61
Loeffler Syndrome in FIP1L1-PDGFRA-Positive Myeloid Neoplasm.
Alcalá Ramírez Del Puerto M, Sánchez Sánchez C, Piñero Uribe I, et al.
JACC. Case reports 2026; (31(5)):106296 doi:10.1016/j.jaccas.2025.106296.
PMID: 41379052 - 62
JPOS/JASCC clinical guidelines for psychological distress in adult cancer patients: a summary of recommendations.
Fujisawa D, Yoshikawa E, Fujimori M, et al.
Japanese journal of clinical oncology 2026; (56(3)):324-336 doi:10.1093/jjco/hyaf209.
PMID: 41459813 - 63
Exploring psychological distress, appraisal, and coping during the scan result journey: a qualitative study of young and middle-aged Chinese adults with advanced cancer.
Li X, Lu Y, Fan Y, et al.
BMC cancer 2026; (26(1)).
PMID: 41906115 - 64
Psychological distress and quality of life in patients with indolent non-Hodgkin lymphoma.
Kuiper JW, Custers JAE, Kleinjan A, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2026; (34(5)).
PMID: 42082740 - 65
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (FIP1L1::PDGFRA) complicated by Loeffler's endocarditis leading to stroke.
Luo R, Qi X
BMC neurology 2026; (26(1)).
PMID: 42135668 - 66
Loeffler Endocarditis: Multimodality Imaging of a Common Cardiac Phenotype in Distinct Hypereosinophilic Syndromes.
Salar T, Feitell S, Parikh V, Baibhav B
JACC. Case reports 2026; (31(31)):108674 doi:10.1016/j.jaccas.2026.108674.
PMID: 42301176 - 67
Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report.
Wang H, Zhu F, Hu H
Frontiers in cardiovascular medicine 2026; (13()):1924869 doi:10.3389/fcvm.2026.1924869.
PMID: 42688267 - 68
Heart failure and predictors of outcome in eosinophilic myocarditis: a real-world cohort study.
Ullrich FTH, Schönermarck U, Milger K, et al.
Frontiers in medicine 2026; (13()):1887831 doi:10.3389/fmed.2026.1887831.
PMID: 42718441 - 69
Eosinophilic myocarditis in platelet-derived growth factor receptor α-rearranged myeloid neoplasm with central nervous system involvement: a case report.
Aloini MC, Segreti A, Melfi R, Grigioni F
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2026; doi:10.4081/monaldi.2026.4166.
PMID: 42948984